OneDigital Investment Advisors LLC Lowers Stake in IQVIA Holdings Inc. (NYSE:IQV)

OneDigital Investment Advisors LLC reduced its position in shares of IQVIA Holdings Inc. (NYSE:IQV) by 3.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 14,436 shares of the medical research company’s stock after selling 441 shares during the quarter. OneDigital Investment Advisors LLC’s holdings in IQVIA were worth $3,421,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of IQV. Canada Pension Plan Investment Board lifted its stake in IQVIA by 6.6% in the 2nd quarter. Canada Pension Plan Investment Board now owns 3,403,488 shares of the medical research company’s stock valued at $719,634,000 after buying an additional 211,653 shares in the last quarter. Lazard Asset Management LLC lifted its stake in IQVIA by 0.9% in the 1st quarter. Lazard Asset Management LLC now owns 3,263,944 shares of the medical research company’s stock valued at $825,416,000 after buying an additional 30,014 shares in the last quarter. Farallon Capital Management LLC lifted its stake in IQVIA by 3.1% in the 2nd quarter. Farallon Capital Management LLC now owns 2,923,032 shares of the medical research company’s stock valued at $618,046,000 after buying an additional 86,870 shares in the last quarter. Capital Research Global Investors lifted its stake in IQVIA by 7.2% in the 1st quarter. Capital Research Global Investors now owns 2,138,802 shares of the medical research company’s stock valued at $540,882,000 after buying an additional 143,533 shares in the last quarter. Finally, Impax Asset Management Group plc lifted its stake in IQVIA by 9.7% in the 3rd quarter. Impax Asset Management Group plc now owns 1,793,010 shares of the medical research company’s stock valued at $423,885,000 after buying an additional 157,809 shares in the last quarter. 89.62% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other IQVIA news, insider Eric Sherbet sold 1,300 shares of the stock in a transaction that occurred on Tuesday, August 27th. The shares were sold at an average price of $246.33, for a total transaction of $320,229.00. Following the sale, the insider now directly owns 19,536 shares in the company, valued at $4,812,302.88. This represents a 6.24 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders own 1.60% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on IQV shares. BTIG Research decreased their price target on shares of IQVIA from $290.00 to $260.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. Truist Financial decreased their target price on shares of IQVIA from $286.00 to $265.00 and set a “buy” rating on the stock in a research note on Monday, November 4th. Jefferies Financial Group cut IQVIA from a “buy” rating to a “hold” rating and cut their price target for the company from $266.00 to $242.00 in a report on Wednesday, July 24th. JPMorgan Chase & Co. lowered their price objective on IQVIA from $279.00 to $240.00 and set an “overweight” rating on the stock in a research note on Tuesday, November 5th. Finally, Redburn Atlantic initiated coverage on shares of IQVIA in a research report on Monday, October 14th. They set a “buy” rating and a $276.00 price target on the stock. Five research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $259.13.

IQVIA Stock Performance

Shares of IQVIA stock opened at $192.63 on Friday. The company has a debt-to-equity ratio of 1.76, a current ratio of 0.81 and a quick ratio of 0.81. The stock has a market capitalization of $34.96 billion, a price-to-earnings ratio of 25.28, a price-to-earnings-growth ratio of 2.17 and a beta of 1.51. The business has a 50-day moving average of $227.96 and a 200 day moving average of $228.59. IQVIA Holdings Inc. has a 12 month low of $189.63 and a 12 month high of $261.73.

IQVIA Company Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.